ID

34590

Descripción

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01941199

Link

https://clinicaltrials.gov/show/NCT01941199

Palabras clave

  1. 19/1/19 19/1/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

19 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 2 Diabetes Mellitus NCT01941199

Eligibility Type 2 Diabetes Mellitus NCT01941199

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age between 20 to 45, healthy male subjects(at screening)
Descripción

ID.1

Tipo de datos

boolean

body weight between 55kg - 90kg, bmi between 18.0 - 27.0
Descripción

ID.2

Tipo de datos

boolean

fpg 70-125mg/dl glucose level(at screening)
Descripción

ID.3

Tipo de datos

boolean

subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress.
Descripción

ID.4

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, neurology, immunology, pulmonary, endocrine, hematooncology, cardiology, mental disorder)
Descripción

ID.5

Tipo de datos

boolean

subject who had gi tract disease(crohn's disease, ulcer, acute or chronic pancreatitis) or surgery(appendectomy, hernioplasty are excluded)
Descripción

ID.6

Tipo de datos

boolean

subject who had drug(aspirin, antibiotics) hypersensitivity reaction
Descripción

ID.7

Tipo de datos

boolean

subject who already participated in other trials in 2 months
Descripción

ID.8

Tipo de datos

boolean

subject who had whole blood donation in 2 months, or component blood donation in 1 months or transfusion in 1 months currently.
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01941199

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age between 20 to 45, healthy male subjects(at screening)
boolean
ID.2
Item
body weight between 55kg - 90kg, bmi between 18.0 - 27.0
boolean
ID.3
Item
fpg 70-125mg/dl glucose level(at screening)
boolean
ID.4
Item
subject who totally understand the progress of this clinical trials, make decision by his free will, and signed a consent form to follow the progress.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
subject who has past or present history of any diseases following below.(liver including hepatitis virus carrier, kidney, neurology, immunology, pulmonary, endocrine, hematooncology, cardiology, mental disorder)
boolean
ID.6
Item
subject who had gi tract disease(crohn's disease, ulcer, acute or chronic pancreatitis) or surgery(appendectomy, hernioplasty are excluded)
boolean
ID.7
Item
subject who had drug(aspirin, antibiotics) hypersensitivity reaction
boolean
ID.8
Item
subject who already participated in other trials in 2 months
boolean
ID.9
Item
subject who had whole blood donation in 2 months, or component blood donation in 1 months or transfusion in 1 months currently.
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial